Skip to main content
. 2020 Sep 14;174(12):1159–1167. doi: 10.1001/jamapediatrics.2020.3009

Table 1. Prevalence at Birth of cCMV and of Microcephaly Without Comorbid Neural Tube Defects Stratified by Patient Characteristics in Pooled Medicaid Analytic eXtract (2000-2013) and MarketScan (2011-2015) Databases.

Characteristic No. (%) Prevalence per 10 000 (95% CI) Infants with microcephaly, No. (%) Prevalence per 10 000 (95% CI)
Pregnancies Infants with cCMV diagnosis
Total No. 2 338 580 336 1.4 (1.3-1.6) 679 2.9 (2.7-3.1)
Maternal age, y
≤19 284 564 (12.2) 79 (23.5) 2.8 (2.2-3.4) 87 (12.8) 3.1 (2.4-3.7)
20-24 746 301 (31.9) 105 (31.3) 1.4 (1.1-1.7) 204 (30.0) 2.7 (2.4-3.1)
25-29 588 227 (25.1) 63 (18.8) 1.1 (0.8-1.3) 189 (27.8) 3.2 (2.8-3.7)
30-34 456 318 (19.5) 52 (15.5) 1.1 (0.8-1.4) 115 (16.9) 2.5 (2.1-3.0)
35-39 212 381 (9.1) 29 (8.6) 1.4 (0.9-1.9) 70 (10.3) 3.3 (2.5-4.1)
≥40 50 789 (2.2) <11a NA 14 (2.1) 2.8 (1.3-4.2)
Infant sexb
Male 1 192 507 (51.0) 186 (55.4) 1.6 (1.3-1.8) 263 (38.7) 2.2 (1.9-2.5)
Female 1 136 353 (48.6) 147 (43.8) 1.3 (1.1-1.5) 414 (61.0) 3.6 (3.3-4.0)
Gestation
Multiple 80 186 (3.4) 38 (11.3) 4.7 (3.2-6.2) 55 (8.1) 6.9 (5.0-8.7)
Single 2 258 394 (96.6) 298 (88.7) 1.3 (1.2-1.5) 624 (91.9) 2.8 (2.5-3.0)
Race/ethnicity
White 707 087 (30.2) 97 (28.9) 1.4 (1.1-1.6) 204 (30.0) 2.9 (2.5-3.3)
American Indian or Alaskan Native 30 497 (1.3) <11a NA 12 (1.8) 3.9 (1.7-6.2)
Asian 68 785 (2.9) 12 (3.6) 1.7 (0.8-2.7) 18 (2.7) 2.6 (1.4-3.8)
Black or African American 571 303 (24.4) 109 (32.4) 1.9 (1.5-2.3) 230 (33.9) 4.0 (3.5-4.5)
Hispanic or Latino 251 696 (10.8) 18 (5.4) 0.7 (0.4-1.0) 36 (5.3) 1.4 (1.0-1.9)
Otherc 127 962 (5.5) 18 (5.4) 1.4 (0.8-2.1) 42 (6.2) 3.3 (2.3-4.3)
Parityd
Multipara 1 343 179 (57.4) 156 (46.4) 1.2 (1.0-1.3) 398 (58.6) 3.0 (2.7-3.3)
Primipara 414 151 (17.7) 103 (30.7) 2.5 (2.0-3.0) 144 (21.2) 3.5 (2.9-4.0)
Maternal conditions
Hypertension (preexisting) 55 941 (2.4) <11a NA 30 (4.4) 5.4 (3.4-7.3)
Preeclampsia 100 319 (4.3) 29 (8.6) 2.9 (1.8-3.9) 44 (6.5) 4.4 (3.1-5.7)
Placental abruption 24 521 (1.0) 12 (3.6) 4.9 (2.1-7.7) 26 (3.8) 10.6 (6.5-14.7)
Diabetes (preexisting) 41 639 (1.8) <11a NA 42 (6.2) 10.1 (7.0-13.1)
Fever in pregnancy 42 407 (1.8) 16 (4.8) 3.8 (1.9-5.6) <11a NA
Asthma (preexisting and gestational onset) 147 819 (6.3) 25 (7.4) 1.7 (1.0-2.4) 55 (8.1) 3.7 (2.7-4.7)
Maternal substance use in pregnancy
Any anticonvulsants 25 979 (1.1) <11a NA 15 (2.2) 5.8 (2.9-8.7)
Tobacco 197 789 (8.4) 25 (7.4) 1.3 (0.8-1.8) 83 (12.2) 4.2 (3.3-5.1)
Other drug abusee 35 005 (1.5) <11a NA 23 (3.4) 6.6 (3.9-9.3)
Fetal conditions
Preterm birth 247 312 (10.6) 174 (51.8) 7.0 (6.0-8.1) 277 (40.8) 11.2 (9.9-12.5)
Small for gestational age 326 261 (14.0) 138 (41.1) 4.2 (3.5-4.9) 255 (37.6) 7.8 (6.9-8.8)

Abbreviations: cCMV, congenital cytomegalovirus; NA, not applicable.

a

Cell contains fewer than 11 individuals. Therefore, to provide summary prevalence ratios while maintaining anonymity of participants, no additional frequency numbers are provided for this row.

b

A total of 9722 infants were classified as sex unknown and were excluded from analysis.

c

The other race/ethnicity category included Native Hawaiian or other Pacific Islander, Hispanic or Latino and 1 or more races, more than 1 race (Hispanic or Latino not indicated), and unknown.

d

Sociodemographic and parity data available only for the Medicaid Analytic eXtract data set.

e

Includes dependent or nondependent abuse of cannabis, hallucinogens, sedatives, opioids, cocaine, amphetamines, antidepressants, mixed or unspecified drugs, and drug-induced mental disorders (International Classification of Diseases, Ninth Revision codes 292.xx, 304.xx, 305.2x-305.9x, 648.4 from last menstrual period plus 1 day to delivery).